The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions
world1 day ago
India has found multiple deficiencies among drugmakers following wide-ranging inspections across the industry, including a lack of raw materials testing, the health ministry said on Wednesday.
Indian authorities have stepped up scrutiny of drugmakers in recent months after some cough syrups made in the country were linked to the deaths of at least 95 children overseas.
Recent risk-based inspections of 162 factories and 14 public laboratories found issues including "poor documentation, lack of process and analytical validations, absence of self-assessment, absence of quality failure investigation, (and) absence of internal product quality review", it said in a statement.
It also flagged an absence of raw materials testing, a lack of measures to avoid cross-contamination, an absence of professionally qualified employees, and faulty design of manufacturing and testing areas.
India's $41 billion pharmaceutical industry is one of the biggest globally, known for providing cheaper alternatives to western products, but the recent cough syrup-related deaths have hurt that image.
The government has stopped production at four drugmakers so far after contaminants were flagged in their cough syrups by agencies including the World Health Organization. The companies deny any wrongdoing.
The ministry said it has upgraded 'Good Manufacturing Practices' under the Drugs and Cosmetics Rules to check the deficiencies found during the inspections.
The upgrade includes the introduction of quality risk management, product quality review, supplier audit and approval, and validation of equipment.
Large drugmakers have been given six months and small manufacturers 12 months to transition to the upgraded manufacturing requirements, the ministry said.
India has tightened its testing of cough syrup exports since June, making it mandatory for companies to obtain a certificate of analysis from a government laboratory before exporting products.
The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions
world1 day ago
Around 100 of these chemicals are considered to be of 'high concern' to human health, according to lead study author Geueke
world1 day ago
Opinion poll shows Marxist-leaning Dissanayake leading
world1 day ago
The government will build consensus and take all legal aspects into consideration before moving forward, says Information Minister Vaishnaw
world1 day ago
She held a meeting at Windsor Castle with staff from the Royal Foundation Centre for Early Childhood
world1 day ago
Devices modified by Israel at production, Lebanon security sources say
world1 day ago
Top US diplomat is visiting Egypt hoping to advance efforts to achieve a ceasefire in Gaza and strengthen ties with Cairo
world1 day ago
A UNRWA official said the Israeli government is also 'increasingly phasing out representation from those engaged in reporting on the atrocities'
world1 day ago